Barriers to Human Papillomavirus Vaccine Acceptability in Israel

Vaccine

Volumn 31, Issue SUPPL.8, 2013, Pages 153-157

  Fisher, William A ^a   Laniado, Hila ^b   Shoval, Hila ^c   Hakim, Marwan ^d,e   Bornstein, Jacob ^e,f  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b TEL AVIV UNIVERSITY   (Israel)

^c MSD   (Israel)

^d Nazareth Hospital   (Israel)

^e BAR ILAN UNIVERSITY   (Israel)

^f WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

Attitudes; Cervical cancer; Circumcision; HPV; HPV vaccine acceptability; Israel; Social support

Indexed keywords

WART VIRUS VACCINE;

ANUS CANCER; ATTITUDE TO HEALTH; ATTITUDE TO ILLNESS; CANCER IMMUNIZATION; CANCER INCIDENCE; COST UTILITY ANALYSIS; DRUG COST; ETHNICITY; GENERAL PRACTITIONER; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; ISRAEL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELIGION; REVIEW; SEXUAL PROMISCUITY; UTERINE CERVIX CANCER; VAGINA CANCER; VIRUS IMMUNITY; VULVA CARCINOMA;

EID: 84887602486     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.107     Document Type: Review

References (33)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: (last accessed June 2013). http://globocan.iarc.fr/.
2. Shavit O., Roura E., Barchana M., Diaz M., Bornstein J. Burden of human papillomavirus infection and related diseases in Israel. Vaccine 2013, 31S:I32-I41.
3. Forman D., de Martel C., Lacey C.J., Soerjomataram I., Lortet-Tieulent J., Bruni L., et al. Global burden of human papillomavirus and related diseases. Vaccine 2012, 20(30 Suppl 5):F12-F23.
4. Shavit O., Raz R., Stein S., Chodick G., Schejter E., Cohen R., Shalev V. Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN 2/3 and cervical cancer. Ppl Health Econ Health Policy 2012, 10:87-97.
5. Huang C.M. Human papillomavirus and vaccination. Mayo Clinic Proc 2008, 83:701-707.
6. Kahn J.A., Rosenthal S.L., Jin Y., Huang B., Namakydoust A., Zimet G.D. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 2008, 111:1103-1110.
7. Conroy K., Rosenthal S.L., Zimet G.D., Jin Y., Bernstein D.I., Glynn S., et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women's Health 2009, 18:1679-1686.
8. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13 through 17 years - United States, 2010. MMWR 2011, 60:1117-1123.
9. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States. National Immunization Survey-Adult 2007. Prev Med 2009, 48:426-431.
10. Srugo I., Ashkenazi S., Bornstein J., Miron D., Stein M. Guidelines for HPV vaccination of the task force on pediatric HPV vaccination. Israeli Journal of Pediatrics 2009, 67:2-4.
11. Bornstein J., Shavit O. Human papillomavirus-associated diseases in Israel - the controversy continues. Vaccine 2013, 31S:v-viii.
12. Ginsberg G.M., Fisher M., Ben-Shahar I., Bornstein J. Cost-utility analysis of vaccination against HPV in Israel. Vaccine 2007, 25:6677-6691.
13. The 312 seating of the 18th Knesset. Available at: (last accessed June 2013). http://www.knesset.gov.il/plenum/data/05570811.doc.
14. Albero G., Villa L.L., Lazcano-Ponce E., Fulp W., Papenfuss M.R., Nyitray A.G., et al. Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study. BMC Infect Dis 2013, 13:18.
15. Gamett P. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 2005, 191(1):S97-S106.
16. National Council for Children's Welfare, Center for Research and Development. Children in Israel 2010, Statistical Yearbook. December 2010, Jerusalem [in Hebrew].
17. Stein-Zamir C., Zentner G., Tallen-Gozani E., Grotto I. The Israel National Immunization Registry. Isr Med Assoc J 2010, 12:296-300.
18. Ben Natan M., Aharon O., Palickshvili S., Gurman V. Attitude of Israeli mothers with vaccination of their daughters against human papilloma virus. J Pediatr Nurs 2011, 26(1):70-77.
19. Israeli population by groups. Israel central bureau of statistics. Available at: (last accessed June 2013). http://www.cbs.gov.il/yarhon/b1_h.htm.
20. Zimet G.D., Weiss T.W., Rosenthal S.L., Good M.B., Vichnin M.D. Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Women's Health 2010, 10:27.
21. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women ages 19-26: importance of a physician's recommendation. Vaccine 2011, 29:890-895.
22. Merck Sharp & Dohme Israel. Available at: (last accessed June 2013). http://www.msd.co.il/.
23. HPV website from Merck Sharp & Dohme Israel. Available at: (last accessed June 2013). http://www.hpv.co.il/.
24. Donovan B., Franklin N., Guy R., Grulich A.E., Regan D.G., Ali H., et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011, 11(1):39-44.
25. Black L.L., Zimet G.D., Short M.B., Sturm L., Rosenthal S.L. Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine 2009, 27:1668-1673.
26. Gilbert P., Brewer N.T., Reiter P.L., Ng T.W., Smith J.S. HPV vaccine acceptability in heterosexual, gay, and bisexual men. Am J Mens Health 2011, 5:297-305.
27. Fishbein M., Ajzen I. Belief, attitude, intention and behavior: An introduction to theory and research 1975, Addison-Wesl, Reading, MA.
28. Ajzen I., Fishbein M. Understanding attitudes and predicting social behavior 1980, Englewood Cliffs, NJ, Prentice Hall.
29. Sheppard B.H., Hartwick J., Warshaw P.R. The theory of reasoned action: A meta-analysis of past research with recommendations for modifications for future research. J Consum. Res. 1988, 15:325-343.
30. Albarracin D., Fishbein M., Johnson B.T., Muellerleile P.A. Theory of Reasoned Action and Theory of Planned Behavior as models of condom use: A meta-analysis. Psychol Bull 2001, 147(1):142-161.
31. Ajzen I. Theory of planned behavior. Organ Behav Hum Dec 1991, 50:179-211.
32. Ajzen I., Madden T.J. Prediction of goal-directed behavior: Attitudes, intentions, and perceived behavioral control. J Exp Soc Psych 1986, 22:453-474.
33. Armitage C.J., Conner M. Efficacy of the theory of planned behaviour: A meta-analytic review. Br J Soc Psych 2001, 40:471-499.